Medite Cancer Diagnostics Inc Overview
- Founded
- 1998
- Status
- Public
- Employees
- 69
- Stock Symbol
- MDIT
- Share Price
- $0.03
- (As of Thursday Closing)
Medite Cancer Diagnostics Inc General Information
Description
Medite Cancer Diagnostics Inc is a US-based company which specializes in the marketing and selling of MEDITE core products (instruments and consumables), manufacturing, development of new solutions in histology and cytology and marketing of molecular biomarkers. The company manufactures medical devices and consumables are for detection, risk assessment and diagnosis of cancerous and precancerous conditions and related diseases. Medite operates through the single segment for cancer diagnostics instruments and consumables for histology and cytology laboratories. It offers a range of histology laboratory devices for processing tissue, from receiving the tissue in the laboratory to the final diagnosis.
Contact Information
Website
Formerly Known As
Molecular Diagnostics, Cytocore
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Surgical Devices
Other Industries
Monitoring Equipment
Stock Exchange
PINX
Primary Office
- 414 North Orleans Street
- Suite 510
- Chicago, IL 60654
- United States
Medite Cancer Diagnostics Inc Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.03 | $0.05 | $0.01 - $0.08 | $2.66M | 5.01K |
Medite Cancer Diagnostics Inc Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2018 | FY 2017 31-Dec-2017 | FY 2016 31-Dec-2016 | FY 2015 31-Dec-2015 |
|---|---|---|---|---|
| EV | 21,111 | 12,973 | 16,528 | 27,241 |
| Revenue | 8,133 | 6,813 | 9,238 | 9,887 |
| EBITDA | (3,499) | (6,156) | (1,387) | (400) |
| Net Income | (5,326) | (6,811) | (2,163) | (859) |
| Total Assets | 17,651 | 15,956 | 17,570 | 18,378 |
| Total Debt | 6,052 | 5,290 | 4,090 | 3,905 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Medite Cancer Diagnostics Inc Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Medite Cancer Diagnostics Inc‘s full profile, request access.
Request a free trialMedite Cancer Diagnostics Inc Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000 000000 | Self | Board Member | 000 0000 |
Medite Cancer Diagnostics Inc Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial